Actavis (ACT) Announces 42% Increase to $2.01 in Second Quarter 2013 Non-GAAP Earnings Per Share
7/25/2013 7:12:28 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
PARSIPPANY, N.J., July 25, 2013 — /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today reported net revenue increased 46.8 percent to $1.99 billion for the second quarter 2013, compared to $1.36 billion in the second quarter 2012. On a non-GAAP basis, diluted earnings per share for the second quarter 2013 were $2.01, compared to $1.42 per diluted share in the second quarter 2012, an increase of 41.5 percent.
Help employers find you! Check out all the jobs and post your resume.